Selective potentiation of paclitaxel (Taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines

Molecular Pharmacology

Volumn 60, Issue 2, 2001, Pages 290-301

  McDaid, H M ^a   Horwitz, S B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE; PACLITAXEL;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CRYSTALLOGRAPHY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STIMULUS RESPONSE;

EID: 0034920013     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.60.2.290     Document Type: Article

References (55)

1. Clinical development of Taxol
2. Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells
3. Raf-1/Bcl-2 phosphorylation: A step from microtubule damage to cell death
4. MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L) and Mcl-1 and promotes survival of human pancreatic cancer cells
5. Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: Effect on NF-kappaB, AP-1, JNK, MAPKK and apoptosis
6. The total synthesis of eleutherobin: A surprise ending
7. Quantitative analysis of dose-effect relationships: The combined effect of multiple drugs or enzyme inhibitors
8. Differential involvement of MEK kinase 1 (MEKK1) in the induction of apoptosis in response to microtubule-targeted drugs versus DNA damaging agents
9. Transcription factor ATF2 regulation by the JNK signal transduction pathway
10. Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells
11. Characterization of Raf-1 activation in mitosis
12. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf
13. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway
14. Role of mitogen-activated protein kinase in Taxol-induced apoptosis in human leukemic U937 cells
15. Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis
16. MEK inhibition enhances paclitaxel-induced tumor apoptosis
17. Phase I and pharmacokinetic study of oral paclitaxel
18. Structure-activity profiles of eleutherobin analogs and their cross-resistance in Taxol-resistant cell lines
19. Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver
20. The total syntheses of epothilones A and B
21. 2/M arrest
22. Regulation and function of the JNK subgroup of MAP kinases
23. Cell swelling activates stress-activated protein kinases, p38 MAP kinase and JNK, in renal epithelial A6 cells
24. Structure of the alpha beta tubulin dimer by electron crystallography
25. Possible involvement of poly(ADP-ribosyl) polymerase in triggering stress-induced apoptosis
26. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: Three-year results
27. Characterization of cell lines showing growth control isolated from both the wild type and a leucyl-tRNA synthetase mutant of Chinese hamster ovary cells
28. Characterization of the Taxol binding site on the microtubule. Identification of Arg(282) in beta-tubulin as the site of photoincorporation of a 7-benzophenone analogue of Taxol
29. 3′-(P-azidobenzamido)taxol photolabels the N-terminal 31 amino acids of beta-tubulin
30. Characterization of the Taxol binding site on the microtubule. 2-(m-Azidobenzoyl)Taxol photolabels a peptide (amino acids 217-231) of beta-tubulin
31. Association of mitogen-activated protein kinase with the microtubule cytoskeleton
32. Screening of a library of phage-displayed peptides identifies human Bcl-2 as a Taxol-binding protein
33. Mitotic phosphorylation of Bcl-2 during normal cell cycle progression and Taxol-induced growth arrest
34. Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase
35. Increased MAPK expression and activity in primary human hepatocellular carcinoma
36. The MAPK signaling cascade
37. Activation of the MKK/ERK pathway during somatic cell mitosis: Direct interactions of active ERK with kinetochores and regulation of the mitotic 3F3/2 phosphoantigen
38. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells
39. Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase
40. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
41. Gramscale synthesis of (+)-discodermolide
42. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK and p38) signaling pathways in human KB-3 carcinoma cells
43. Structure-activity relationships of the epothilones and the first in vivo comparison with paclitaxel
44. Mechanisms of Taxol-induced cell death are concentration dependent
45. MAP kinase becomes stably activated at metaphase and is associated with microtubule-organizing centers during meiotic maturation of mouse oocytes
46. Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells
47. Microtubule-interfering agents activate c-jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways
48. MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis
49. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human
50. Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals
51. 2/M
52. Taxol mediates serine phosphorylation of the 66-kDa She isoform
53. Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1
54. MEK kinase 1 (MEKK1) transduces c-jun NH2-terminal kinase activation in response to changes in the microtubule cytoskeleton
55. Active MAP kinase in mitosis: Localization at kinetochores and association with the motor protein CENP-E